The company is overvalued at 37.40 per share with modest projections ahead. On a scale of 0 to 100, Qiagen NV holds a
performance score of 14. The company holds a Beta of -0.0418, which implies not very significant fluctuations relative to the market. Let's try to break down what Qiagen's beta means in this case. As returns on the market increase, returns on owning Qiagen NV are expected to decrease at a much lower rate. During the bear market, Qiagen NV is likely to outperform the market. Although it is vital to follow
Qiagen NV current trending patterns, it is good to be conservative about what you can do with the information regarding equity existing
price patterns. The philosophy towards forecasting
future performance of any stock is to evaluate the business as a whole together with its past performance, including all
available fundamental and
technical indicators. By analyzing
Qiagen NV technical indicators, you can presently evaluate if the expected return of 0.26% will be sustainable into the future. Please employ Qiagen NV
variance, as well as the
relationship between the value at risk and
skewness to make a quick decision on whether Qiagen NV historical
price patterns will revert.
The performance of Qiagen NV in the marketplace will significantly impact your decision to invest in its stock. Revenue growth, profitability, competitive positioning, management quality, and industry trends can influence Qiagen NV's
stock prices. When investing in Qiagen NV, there are several factors to consider and potential outcomes to expect. As a company performs well, its stock price may increase, allowing investors to benefit from price appreciation. However, Qiagen Stock can experience significant price fluctuations due to market conditions, economic factors, industry trends, or company-specific news. This is why investing in stocks such as Qiagen NV carries risks, including the potential for capital loss. Stock prices can decline, and investors may incur losses if they sell shares at a lower price than their initial investment.
How important is Qiagen NV's Liquidity
Qiagen NV
financial leverage refers to using borrowed capital as a funding source to finance Qiagen NV ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Qiagen NV financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to Qiagen NV's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of Qiagen NV's financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the
breakdown between Qiagen NV's total debt and its cash.
What do experts say about Qiagen?
Stock analysis is a method for investors and traders to make buying and selling decisions. By studying and evaluating past and current data, investors and traders attempt to gain an edge in the markets by making informed decisions.
Analysis ConsensusWhat is driving Qiagen NV Investor Appetite?
Qiagen NV has a total of 228.64 Million outstanding shares. The majority of Qiagen NV
outstanding shares are owned by
third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Qiagen NV to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Qiagen NV. Please pay attention to any change in the institutional holdings of Qiagen NV as this could imply that something significant has changed or about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Ownership Breakdown
Retail Investors21.83% | | Institutions75.43% |
| Retail Investors | 21.83 |
| Insiders | 2.74 |
| Institutions | 75.43 |
Qiagen is expecting lower volatility in September
Latest risk adjusted performance is at 0.27. Qiagen NV has low volatility with Treynor Ratio of -5.13, Maximum Drawdown of 5.92 and kurtosis of 2.59. However, we advice all investors to further analyze Qiagen NV to make certain all market information is desiminated and is consistent with the current expectations about Qiagen NV upside potential.
Our Conclusion on Qiagen NV
Whereas other entities within the diagnostics & research industry are still a little expensive, even after the recent corrections, Qiagen NV may offer a potential longer-term growth to institutional investors. With a somewhat neutral outlook on your 30 days horizon, it may be better to hold off any trading activity and neither pick up new shares of Qiagen nor exit your existing holdings in the Stock. It seems the expected volatility has not yet been fully factored into the current price. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Qiagen NV.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Rifka Kats is a Member of Macroaxis Editorial Board. Rifka writes about retail product and service companies from the perspective of a regular consumer and sophisticated investor at the same time. She is passionate about corporate ethics and equality in the workforce.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Rifka Kats do not own shares of Qiagen NV. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
editors@macroaxis.com